Opportunity Information: Apply for HRSA 13 282
Apply for HRSA 13 282
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Providing Support for the Collaborative Improvement and Innovation Network (CoIIN) to Reduce Infant M" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.110 Maternal and Child Health Federal Consolidated Programs.
- This funding opportunity was created on Jul 9, 2013 and posted on Jul 3, 2013.
- Applicants must submit their applications by Aug 5, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) County governments.
- As cited in 42 CFR Part 51a.3 (a), any public or private entity, including an Indian tribe or tribal organization (as defined at 25 U.S.C. 450b), is eligible to apply for Federal funding under this announcement. Community based organizations, including faith based organizations, are also eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Providing Support for the Collaborative Improvement and Innovation Network (CoIIN) to Reduce Infant Mortality" (Funding Opportunity Number HRSA-13-282), is a Health Resources and Services Administration (HRSA) cooperative agreement aimed at accelerating measurable reductions in infant mortality and improving birth outcomes. The program is built around the idea that states and partners can move faster and more effectively when they work as a structured learning network, share data and lessons in real time, and use proven quality improvement (QI) methods to test, refine, and scale interventions. In practice, the award is meant to fund an entity that can serve as a central support and technical assistance hub for a multi-state collaborative focused on infant mortality reduction.
The core purpose of the project has three connected parts. First, the recipient is expected to support collaborative learning, innovation, and QI efforts by providing guidance and hands-on technical assistance to participating jurisdictions in HRSA Regions I, II, III, VII, VIII, IX, and X. This includes helping states and partners use collaborative learning models effectively (for example, structured peer learning, shared measurement, rapid-cycle testing, and cross-state coaching) and apply QI principles and practices to maternal and infant health work. Second, the recipient is expected to promote and help implement evidence-based strategies known to reduce infant mortality and improve birth outcomes, ensuring that the work is grounded in interventions with demonstrated effectiveness rather than purely exploratory approaches. Third, the project is designed to help scale up successful interventions by stimulating coordinated action across states and among multiple partners, with the goal of moving beyond isolated pilots into broader adoption.
HRSA indicates that the cooperative agreement is expected to produce measurable improvements within a relatively short timeframe, approximately 12 to 18 months, among participating states in specified strategy areas. Beyond outcome improvement, the opportunity emphasizes building stronger alignment and synergy among key leaders and stakeholders, including State Health Officials (SHOs), Maternal and Child Health Directors, and state and national public and private partners. Another explicit deliverable is the creation of a unified message and a practical collection of best practices drawn from participating states experiences, packaged in a way that other states and jurisdictions can adopt and adapt to their own contexts to support infant mortality reduction and better birth outcomes.
In terms of funding structure, HRSA planned a single award (Expected Awards: 1) with a total award amount fixed at 3,000,000 dollars, functioning as both the award ceiling and award floor. The funding instrument is a cooperative agreement, which typically means substantial involvement by the federal agency compared with a standard grant, such as active collaboration, guidance, and shared expectations around implementation and performance. There is no cost sharing or matching requirement listed for applicants.
Eligibility is broad. Under 42 CFR Part 51a.3(a), any public or private entity is eligible, including Indian tribes or tribal organizations (as defined at 25 U.S.C. 450b). The eligible applicant types listed also include state and local governments, county and city or township governments, special district governments, independent school districts, and nonprofit organizations with 501(c)(3) status (other than institutions of higher education). Community-based organizations, including faith-based organizations, are specifically noted as eligible as well, indicating HRSA was open to a wide range of organizations capable of providing the kind of multi-state coordination, technical assistance, and improvement-science support the CoIIN model requires.
Key administrative details include the posting date of July 3, 2013, with an application closing date of August 5, 2013, and an archive date of October 4, 2013. The CFDA number associated with the program is 93.110 (Maternal and Child Health Federal Consolidated Programs). HRSA provided an additional information link through its grants portal and directed applicants who had trouble accessing the announcement to contact the HRSA Call Center at CallCenter@HRSA.GOV or by phone at 877-464-4772.
Frequently Asked Questions (FAQs)
1) What is the title and funding opportunity number for this grant?
The opportunity is titled "Providing Support for the Collaborative Improvement and Innovation Network (CoIIN) to Reduce Infant Mortality" and the Funding Opportunity Number is HRSA-13-282.
2) Which federal agency is offering this opportunity?
This is a Health Resources and Services Administration (HRSA) funding opportunity.
3) What type of funding instrument is this?
The funding instrument is a cooperative agreement. This typically involves substantial federal involvement compared with a standard grant, including active collaboration, guidance, and shared expectations around implementation and performance.
4) What is the overall purpose of this cooperative agreement?
The award is intended to fund an entity that can serve as a central support and technical assistance hub for a multi-state collaborative focused on reducing infant mortality and improving birth outcomes, using structured learning networks, real-time data and lesson sharing, and proven quality improvement (QI) methods.
5) What are the core components the recipient is expected to deliver?
The project purpose has three connected parts: (1) support collaborative learning, innovation, and QI efforts through guidance and hands-on technical assistance; (2) promote and help implement evidence-based strategies known to reduce infant mortality and improve birth outcomes; and (3) help scale successful interventions by stimulating coordinated action across states and partners.
6) What does "CoIIN" refer to in this opportunity?
CoIIN refers to the Collaborative Improvement and Innovation Network model, built around structured peer learning, shared measurement, rapid-cycle testing, cross-state coaching, and the use of QI methods to accelerate measurable improvements.
7) Which jurisdictions/regions are the focus of the multi-state collaborative support?
The recipient is expected to provide support to participating jurisdictions in HRSA Regions I, II, III, VII, VIII, IX, and X.
8) What kinds of methods or approaches does HRSA emphasize for this work?
HRSA emphasizes collaborative learning models and quality improvement approaches, including structured peer learning, shared measurement, rapid-cycle testing, and cross-state coaching, along with applying QI principles and practices to maternal and infant health efforts.
9) Is the program focused on exploratory pilots or proven interventions?
The opportunity emphasizes promoting and helping implement evidence-based strategies with demonstrated effectiveness for reducing infant mortality and improving birth outcomes, rather than purely exploratory approaches.
10) What is the expected timeline for measurable improvements?
HRSA indicates the cooperative agreement is expected to produce measurable improvements within a relatively short timeframe of approximately 12 to 18 months among participating states in specified strategy areas.
11) Beyond outcomes, what other deliverables or results are emphasized?
Beyond measurable improvements, the opportunity emphasizes stronger alignment and synergy among key leaders and stakeholders (including State Health Officials and Maternal and Child Health Directors) and the creation of a unified message and a practical collection of best practices from participating states that other jurisdictions can adopt and adapt.
12) Who are the key stakeholders HRSA expects to be aligned through this effort?
Key stakeholders explicitly mentioned include State Health Officials (SHOs), Maternal and Child Health Directors, and state and national public and private partners.
13) How many awards did HRSA plan to make under this opportunity?
HRSA planned a single award (Expected Awards: 1).
14) What is the total funding amount for the award?
The total award amount is $3,000,000, and it is listed as both the award ceiling and the award floor.
15) Is there a cost sharing or matching requirement?
No cost sharing or matching requirement is listed for applicants.
16) Who is eligible to apply?
Eligibility is broad. Under 42 CFR Part 51a.3(a), any public or private entity is eligible, including Indian tribes or tribal organizations (as defined at 25 U.S.C. 450b).
17) What applicant types are specifically mentioned as eligible?
Eligible applicant types listed include state and local governments; county and city or township governments; special district governments; independent school districts; nonprofit organizations with 501(c)(3) status (other than institutions of higher education); and community-based organizations, including faith-based organizations.
18) What is the CFDA number associated with this program?
The CFDA number is 93.110 (Maternal and Child Health Federal Consolidated Programs).
19) When was the opportunity posted and when did it close?
The posting date was July 3, 2013, and the application closing date was August 5, 2013.
20) When was the opportunity archived?
The archive date is October 4, 2013.
21) Where could applicants find additional information or get help accessing the announcement?
HRSA provided an additional information link through its grants portal. Applicants who had trouble accessing the announcement were directed to contact the HRSA Call Center at CallCenter@HRSA.GOV or 877-464-4772.
22) What is the practical role of the funded recipient in this model?
Based on the description, the recipient functions as the central support hub: coordinating a multi-state learning network, providing technical assistance, helping participating jurisdictions apply QI methods, promoting evidence-based strategies, and supporting the spread and scale of successful interventions across states and partners.
Browse more opportunities from the same category: Health
Next opportunity: USAID/Paraguay Democracy and Governance Program
Previous opportunity: Improvement of Animal Models for Stem Cell Based Regenerative Medicine (R24)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 13 282
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 13 282) also looked into and applied for these:
| Funding Opportunity |
|---|
| Morbidity Management and Disability Prevention for Blinding Trachoma and Lymphatic Filariasis Apply for SOL OAA 13 000107 Funding Number: SOL OAA 13 000107 Agency: Agency for International Development Category: Health Funding Amount: $35,000,000 |
| Secondary Analyses of Alcohol and Chronic Disease (R21) Apply for PA 13 251 Funding Number: PA 13 251 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analyses of Alcohol and Chronic Disease (R01) Apply for PA 13 260 Funding Number: PA 13 260 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analyses of Alcohol and Chronic Disease (R03) Apply for PA 13 261 Funding Number: PA 13 261 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Dose Response and Efficacy Studies on the Effects of Vitamin D Supplementation on Functional Outcomes in Elderly (U01) Apply for RFA AG 14 001 Funding Number: RFA AG 14 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implications of New Digital Media Use for Underage Drinking, Drinking Related Behaviors, and Prevention Research (R21) Apply for PA 13 263 Funding Number: PA 13 263 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Implications of New Digital Media Use for Underage Drinking, Drinking Related Behaviors, and Prevention Research (R01) Apply for PA 13 262 Funding Number: PA 13 262 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel NeuroAIDS Therapeutics Integrated Preclinical/Clinical Program (P01) Apply for PAR 13 267 Funding Number: PAR 13 267 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing a Point of Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings SBIR (R43/ R44) Apply for RFA HL 14 010 Funding Number: RFA HL 14 010 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| NEI Center Core Grants for Vision Research (P30) Apply for PAR 13 269 Funding Number: PAR 13 269 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Promotion and Disease Prevention Research Centers Apply for RFA DP 14 001 Funding Number: RFA DP 14 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $900,000 |
| Urban Indian Education and Research Organization Cooperative Agreement Program Apply for HHS 2013 IHS OUIHP 0001 Funding Number: HHS 2013 IHS OUIHP 0001 Agency: Indian Health Service Category: Health Funding Amount: $800,000 |
| NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25) Apply for RFA NS 14 001 Funding Number: RFA NS 14 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Researcher Training and Workforce Development in Methods and Standards for Conducting Patient Centered Outcomes Research Studies (R25) Apply for RFA HS 14 004 Funding Number: RFA HS 14 004 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Instrument Development for Biomedical Applications (R21) Apply for RFA GM 14 014 Funding Number: RFA GM 14 014 Agency: National Institutes of Health Category: Health Funding Amount: $175,000 |
| Mentored Research Scientist Development Award (K01) Apply for PAR 13 245 Funding Number: PAR 13 245 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Formula Grant Program Apply for HRSA 13 278 Funding Number: HRSA 13 278 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Blood Pressure Measurement Technologies for Low Resource Settings in the U.S. and India (U01) Apply for RFA EB 13 001 Funding Number: RFA EB 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Emerging Priorities in Reproductive, Maternal and Newborn Health Apply for APS OAA 13 000005 Funding Number: APS OAA 13 000005 Agency: Agency for International Development Category: Health Funding Amount: $9,000,000 |
| National Center for Construction Safety and Health Research and Translation (U60) Apply for RFA OH 13 001 Funding Number: RFA OH 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 13 282", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.